Eton Pharmaceuticals Inc (ETON) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Eton Pharmaceuticals, Inc. announced the release of Nitisinone Capsules, a new treatment for hereditary tyrosinemia type 1 (HT-1), which must be used alongside a diet low in tyrosine and phenylalanine.
For further insights into ETON stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
